Top Banner
Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60% 5yrs survival.
12

Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Dec 23, 2015

Download

Documents

Lesley Fleming
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Treatment • Localized disease:

Radical nephrectomy.

• Metstatic disease:

Radiation therapy. Immunotherapy

• PROGNOSIS: stage1 80-100% 5yrs survival

stageII 60% 5yrs survival.

Page 2: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Urethelial tumor of the renal pelvis

• 4% of urethelial tumors. Male-Female ratio 4-1. High incidence of multicentric.• Etiology: Risk factor: smoking industrial

dye,solvent, analgesic such as phenacetin,aspirin,caffeine,

acetaminophen.. Pathology: Majority are Transitional cell carcinoma. Rarely squamous cell carcinoma,or adenocarcinoma.

Page 3: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Pathology of TCC.

Metastasis:Regional LNs,Lung,bone.

Staging: TNM:Ta.Tis: confined to mucosa. T1 Invasion of lamina propria. T2 Invasion of muscularis. T3a Invasion of deep muscles. T3b Extension into fat or renal parechyma. T4 Spread to adjacent organs. N+ LNs Metastasis. M+ Distant metastasis.

Page 4: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Clinical Findings:

• Symptoms&Signs: Gross Hematuria. Flank pain. Flank mass(Hydronephrosis). Weight loss anorexia.• Laboratory: Hematuria. Urine cytology(voided urine or ureteric catheter).

Page 5: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

X-ray

• I.V.U.

Page 6: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Retrograde Pyelogram:

Page 7: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Ureteropyeloscopy : Ultrasonography:

C.T.

Page 8: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Treatment:

Localized Tumor :- Nephroureterectomy.

- Conservative :open or endoscopic excision + instillation of immuno-0r chemotherapeutic

Single kidney. Bilateral tumors.

Metastatic Tumor: Chemotherapy.

Page 9: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Adrenal gland:

Benign Tumors:- Adenoma.

Malignant: - Neuroblastoma.

Page 10: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Neuroblastoma of Adrenal Gland

-Origin:Neural crest.- Age:1st 2 ½ yrs.- Poor prognosis.

- Hereditary.- Rarely bilateral.

Clinical Findings: Symptoms:

Abdominal mass (parent). Symptoms related to metastases (failure to thrive,

Fever,malaise,bone pain,constipation,diarrhea.)

Page 11: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Signs:

- Palpable,visible abdominal mass.- In metastatic patient: enlarged nodular liver,mass in

bone,ocular protrusion. - Hypertension.

Laboratory Findings:- Anemia.

- Increase level of serum epinephrine , nor epinephrine, and urinary VMA.

X-ray Findings: U.S, I.V.P, CT, Angiography.

Page 12: Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage1 80-100% 5yrs survival stageII 60%

Treatment:

Localized Tumor:- Tumor Excision followed by radiotherapy to the tumor bed

- Very large tumor :Radiotherapy followed by excision.

Metastatic Tumor: Chemotherapy.